Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBN3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,203
Award facts
- Contract value 100% obligated
- $13,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,203.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The award, issued on November 26, 2025, carries an ultimate completion date of December 18, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, demonstrating the vendor's competitive capability in unrestricted federal pharmaceutical procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to provide Department of Defense healthcare facilities with comprehensive pharmaceutical and medical supply support. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, was awarded to DMS Pharmaceutical Group on November 13, 2025, and positions the company as a critical regional pharmaceutical supplier serving military healthcare operations globally. The PPV-G GEN V structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support recurring medical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBN3?
SPE2DR26FFBN3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FFBN3 worth?
The government has obligated $13,203 on SPE2DR26FFBN3.
Is contract SPE2DR26FFBN3 an order under another contract?
Yes. SPE2DR26FFBN3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBN3 competed?
The extent of competition for SPE2DR26FFBN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award